Mode
Text Size
Log in / Sign up
Phase 2 N=53 Randomized Quadruple-blind Treatment

Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema

Atopic Dermatitis

Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Change From Baseline in the Itch Assessment Score Immediately Following Treatment — 1.93; 2.64 units on a scale — p=<0.001

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
EpiCeram Skin Barrier Emulsion (Device); Experimental Product 1% Colloidal Oatmeal Balm (Drug)
Age
Pediatric, Adult, Older Adult · 12+ yrs
Sex
All
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Primary completion
Apr 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Baseline in the Itch Assessment Score Immediately Following Treatment
1.93; 2.64 <0.001 sig
PRIMARY
Change From Baseline in the Itch Assessment Score 1 Hour After Treatment
3.00; 3.08 <0.001 sig
PRIMARY
Change From Baseline in the Itch Assessment Score 2 Hours After Treatment
3.46; 3.65 <0.001 sig
PRIMARY
Change From Baseline in the Itch Assessment Score 3 Hours After Treatment
3.93; 4.88 <0.001 sig
PRIMARY
Change From Baseline in the Itch Assessment Score 4 Hours After Treatment
3.85; 4.92 <0.001 sig
PRIMARY
Change From Baseline in the Itch Assessment Score 5 Hours After Treatment
4.06; 5.25 <0.001 sig
PRIMARY
Change From Baseline in the Itch Assessment Score 6 Hours After Treatment
4.07; 5.55 <0.001 sig
PRIMARY
Change From Baseline in the Itch Assessment Score 7 Days After Treatment
4.22; 6.53 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement Immediately Following Treatment
48.26; 21.71 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement 1 Hour After Treatment
27.00; 7.84 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement 2 Hours After Treatment
23.20; 7.32 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement 3 Hours After Treatment
21.05; 8.07 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement 4 Hours After Treatment
19.65; 5.75 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement 5 Hours After Treatment
21.48; 7.31 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement 6 Hours After Treatment
18.71; 6.05 <0.001 sig
SECONDARY
Change From Baseline in Mean Corneometer Measurement 7 Days After Treatment
21.01; 7.99 <0.001 sig
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Distracted by Itchy Skin
7.5; 0; 7.5; 0; 7.5; 0
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Calmer Skin
10.0; 7.7; 10.0; 23.1; 5.0; 0
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Smooth Skin
2.5; 0; 2.5; 0; 10.0; 7.7
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Comfortable Showing Skin
15.0; 0; 5.0; 7.7; 12.5; 30.8
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Moisturized Skin
0; 0; 5.0; 0; 7.5; 0
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Touchable Skin
7.5; 7.7; 10.0; 7.7; 7.5; 7.7
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Soft Skin
2.5; 0; 2.5; 7.7; 10.0; 15.4
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Distracted by Itchy Eczema Skin Over Past 2 Days
2.5; 0; 7.5; 0; 35.0; 23.1
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Skin Upon Waking Over Past 2 Days
2.5; 7.7; 0; 0; 22.5; 15.4
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Sleep During Past 2 Days
5.0; 0; 25.0; 23.1; 15.0; 15.4
SECONDARY
Participant Questionnaire on Day 0 Pre-treatment - Comfortable Showing Skin Over Past 2 Days
2.5; 0; 2.5; 0; 27.5; 7.7
SECONDARY
Participant Questionnaire Immediately After Treatment - Product Fast Absorbing
22.5; 53.8; 42.5; 38.5; 15.0; 0
SECONDARY
Participant Questionnaire Immediately After Treatment - Calm Skin
30.0; 53.8; 37.5; 38.5; 15.0; 7.7
SECONDARY
Participant Questionnaire Immediately After Treatment - Moisturized Skin
42.5; 38.5; 40.0; 46.2; 15.0; 7.7
SECONDARY
Participant Questionnaire Immediately After Treatment - Product Does Not Sting
50.0; 53.8; 32.5; 7.7; 2.5; 0
SECONDARY
Participant Questionnaire 4 Hours After Treatment - Long Lasting Moisture
55.0; 38.5; 25.0; 46.2; 2.5; 0
SECONDARY
Participant Questionnaire 4 Hours After Treatment - Skin Feeling Soft
40.0; 46.2; 45.0; 38.5; 7.5; 0
SECONDARY
Participant Questionnaire 5 Hours After Treatment - Long Lasting Moisture
60.0; 61.5; 27.5; 30.8; 2.5; 0
SECONDARY
Participant Questionnaire 5 Hours After Treatment - Skin Feeling Soft
47.5; 53.8; 35.0; 30.8; 2.5; 7.7
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Long Lasting Moisture
60.0; 38.5; 27.5; 53.8; 2.5; 0
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Calms Skin
47.5; 61.5; 35.0; 30.8; 7.5; 7.7
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Distracted by Itchy Skin
52.5; 53.8; 27.5; 38.5; 12.5; 7.7
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Comfortable Showing Skin
35.0; 38.5; 30.0; 38.5; 15.0; 7.7
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Shield for Skin
37.5; 38.5; 37.5; 61.5; 17.5; 0
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Skin Feels Moisturized
57.5; 46.2; 27.5; 38.5; 2.5; 7.7
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Skin Feels Touchable
42.5; 61.5; 35.0; 15.4; 5.0; 7.7
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Skin Feels Soft
50.0; 53.8; 30.0; 30.8; 10.0; 0
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Skin Feels Smooth
45.0; 53.8; 32.5; 30.8; 7.5; 0
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Degree of Distraction by Itchy Eczema Skin
35.0; 23.1; 40.0; 46.2; 17.5; 15.4
SECONDARY
Participant Questionnaire 6 Hours After Treatment - Degree of Comfortableness Showing Skin
22.5; 23.1; 27.5; 30.8; 40.0; 30.8
SECONDARY
Participant Questionnaire 7 Days After Treatment - Skin Feels Calm
60.0; 66.7; 32.5; 33.3; 0; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Distracted by Itchy Skin
55.0; 83.3; 32.5; 16.7; 2.5; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Calmer Skin on Waking
65.0; 66.7; 20.0; 25.0; 5.0; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Comfortable Showing Skin
42.5; 50.0; 32.5; 41.7; 7.5; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Long Lasting Moisture
65.0; 50.0; 22.5; 41.7; 2.5; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Shield for Skin
52.5; 66.7; 30.0; 25.0; 12.5; 8.3
SECONDARY
Participant Questionnaire 7 Days After Treatment - Skin Feels Moisturized
72.5; 50.0; 22.5; 50.0; 0; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Skin Feels Touchable
57.5; 41.7; 22.5; 58.3; 5.0; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Product Does Not Rub Off on Sheets
42.5; 83.3; 25.0; 16.7; 10.0; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Skin Feels Soft
65.0; 50.0; 27.5; 50.0; 2.5; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Moisturized All Day
67.5; 33.3; 17.5; 50.0; 2.5; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Slept Better
45.0; 41.7; 30.0; 58.3; 17.5; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Skin Feels Smooth
60.0; 66.7; 27.5; 25.0; 2.5; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Degree of Distraction by Itchy Eczema Skin
33.3; 33.3; 56.4; 50.0; 5.1; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Skin on Waking
32.5; 8.3; 30.0; 58.3; 27.5; 25.0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Degree of Sleep
45.0; 50.0; 30.0; 50.0; 20.0; 0
SECONDARY
Participant Questionnaire 7 Days After Treatment - Degree of Comfortableness Showing Skin
25.0; 25.0; 37.5; 33.3; 17.5; 33.3

Summary

The objective of this 1 week trial is to evaluate the efficacy of an over-the-counter (OTC) 1% colloidal oatmeal skin protectant cream in adults and children with mild to moderate AD.

Eligibility Criteria

Inclusion Criteria

  • Able to comprehend and follow the requirements of the study (including availability on scheduled visit dates)
  • Male or female of any race or ethnicity, ages 12 and older
  • Diagnosed as having eczema
  • Willing to stop use of all non-assigned moisturizers and/or creams for the entire duration of the study

Exclusion Criteria

  • Known sensitivity to any investigational product ingredient
  • Females who are pregnant , breastfeeding , or planning on becoming pregnant during the study
  • Individuals with a history of skin cancer
  • Use of a therapeutic (over-the-counter or prescription) body wash that contains an active ingredient for eczema
  • Participation in any clinical study within 30 days of Visit 1
  • Active infection of any type at the start of the study
  • Diagnosed as having severe eczema
  • Has a compromised immune system
  • Individuals with any planned surgeries and/or invasive medical procedures during the course of the study
  • Requires greater than 2.0mg/day inhaled or intranasal corticosteroids
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02691507). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search